Innovent Biologics and Incyte Announce Strategic Collaboration and Licensing Agreement for Three Clinical-stage Product Candidates in China Life Science
Cronos Group Confirms Discussions Regarding Potential Investment by Altria Group Cannabis, Life Science
CASI Pharmaceuticals Announces China Market Approval Of Melphalan Hydrochloride For Injection (Trademark: EVOMELA®) Life Science
TRACON Pharmaceuticals and I-Mab Biopharma Announce Strategic Partnerships for Multiple Immuno-Oncology Programs Life Science